Home » VentiRx, Celgene to Develop Cancer Drug
VentiRx, Celgene to Develop Cancer Drug
VentiRx Pharmaceuticals has formed a world-wide collaboration with Celgene Corporation to develop VTX-2337, a highly potent and selective TLR8 agonist for cancer treatment.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
07May
-
14May
-
30May